Craig C. Hopkinson, EVP R&D, Chief Medical Officer: Alkermes ALKS Sell · Filed 25/01/31

Trade details

Type: Insider sale
Amount: $3,234,421.9
Shares · price: 100,918 sh · $32.05 a share
Held after: 44,290 sh
Stock: Alkermes ALKS
Person: Craig C. HopkinsonEVP R&D, Chief Medical Officer
Trade date: 25/01/30
Filed: 25/01/31
Days to filing: 1 days

Sold 69.5% of holdings

Share of holding sold: 69.5%

Alkermes trades, last 26 weeks

What else happened in Alkermes around then

Filed or reported within 30 days of the trade day · 24/12/31~25/03/01

Craig C. Hopkinson's recent trades

Craig C. HopkinsonEVP R&D, Chief Medical Officer
Planned sale10b5-1 planAlkermes
Planned sale10b5-1 plan
Alkermes
ALKS
$422.9K
9,000 sh
$422.9K
Filed 09/01
Traded 09/01
Craig C. HopkinsonEVP R&D, Chief Medical Officer
Planned sale10b5-1 planAlkermes
Planned sale10b5-1 plan
Alkermes
ALKS
$437.2K
9,000 sh
$437.2K
Filed 08/03
Traded 08/03
Craig C. HopkinsonEVP R&D, Chief Medical Officer
Planned sale10b5-1 planAlkermes
Planned sale10b5-1 plan
Alkermes
ALKS
$463.6K
9,000 sh
$463.6K
Filed 07/01
Traded 07/01
Craig C. HopkinsonEVP R&D, Chief Medical Officer
Sell10b5-1 planAlkermes
Sell10b5-1 plan
Alkermes
ALKS
$375K
9,000 sh
$375K
Filed 06/01
Traded 06/01
Craig C. HopkinsonEVP R&D, Chief Medical Officer
Planned sale10b5-1 planAlkermes
Planned sale10b5-1 plan
Alkermes
ALKS
$375K
9,000 sh
$375K
Filed 06/01
Traded 06/01

Craig C. Hopkinson, Chief Officer — sold $3.2M of Alkermes ALKS · 69.5% of holdings · 10b5-1 plan | Whalegun